GeneCradle
Latest round
- Series A
Last raised
- Feb 2022
Total raised
- $47M
Investors
- 8
About GeneCradle
Based in Beijing, China, and established in 2018, GeneCradle is a biotechnology company that engages in the development of gene therapy drugs. Dr Xiaobing Wu, the founder, chairman and CEO of the company, worked at the China CDC Viral Disease Institute. It has partnerships with Beijing Children's Hospital, Peking University Medical School and Guangzhou Women's and Children's Medical Center. On April 6, 2023, it received clinical approval from the State Drug Administration of China for its IND application for "GC101 adeno-associated virus injection", an AAV (adeno-associated virus) gene therapy for the treatment of spinal muscular atrophy. It has production bases in Beijing. The company's main products include gene therapy drugs for spinal muscular atrophy (SMA), gene therapy drugs for hypertriglyceridemia, gene therapy drugs for Pompe disease and gene therapy drugs for familial LCAT (Lecithin-Cholesterol Acyltransferase) deficiency. The company's products are used in genetic diseases, infectious diseases, neurological diseases, blood diseases, metabolic diseases and ophthalmic diseases.
Who invested in GeneCradle
8 investors across 2 rounds
See all investors in GeneCradle
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about GeneCradle
Who invested in GeneCradle?
GeneCradle has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has GeneCradle raised?
GeneCradle has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did GeneCradle last raise money?
GeneCradle's most recent round on record is a Series A, in Feb 2022.
What does GeneCradle do?
Based in Beijing, China, and established in 2018, GeneCradle is a biotechnology company that engages in the development of gene therapy drugs.
Where is GeneCradle headquartered?
GeneCradle is headquartered in Beijing, China.
Which VCs invest in companies like GeneCradle?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at GeneCradle's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like GeneCradle? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.